(Circulation. 1996;94:2572-2579.)
© 1996 American Heart Association, Inc.
Articles |
Molecular Physiology and Pharmacology of HERG
Single-Channel Currents and Block by Dofetilide
the Rammelkamp Center for Research, MetroHealth Campus, Case Western Reserve University, Cleveland, Ohio.
Correspondence to A.M. Brown, Rammelkamp Center, 2500 MetroHealth Dr, Cleveland, OH 44109-1998.
Background The human ether-a-go-go–related gene (HERG) is one locus for the hereditary long-QT syndrome. A hypothesis is that HERG produces the repolarizing cardiac potassium current IKr, with the consequence that mutations in HERG prolong the QT interval by reducing IKr. The elementary properties of HERG are unknown, and as a test of the hypothesis that HERG produces IKr, we compared their elementary properties.
Methods and Results We injected HERG cRNA into Xenopus oocytes and measured currents from single channels or current variance from the noise produced by ensembles of channels recorded from macro patches. Single-channel conductance was dependent on the extracellular potassium concentration ([K]o). At physiological [K]o, it was 2 picosiemens (pS), and at 100 mmol/L [K]o, it was 10 pS. Openings occurred in bursts with a mean duration of 26 ms at -100 mV. Mean open time was 3.2 ms and closed times were 1.0 and 26 ms. In excised macro patches, HERG currents were blocked by the class III antiarrhythmic drug dofetilide, with an IC50 of 35 nmol/L. Dofetilide block was slow and greatly attenuated at positive potentials at which HERG rectifies.
Conclusions The microscopic physiology of HERG and IKr is similar, consistent with HERG being an important component of IKr. The pharmacology is also similar; dofetilide appears to primarily block activated channels and has a much lower affinity for closed and inactivated channels.
Key Words: genes • potassium channels • dofetilide • electrophysiology
This article has been cited by other articles:
 |
|
 |
|
  M. Yamada, N. Hatakeyama, A. P. Malykhina, M. Yamazaki, Y. Momose, and H. I. Akbarali The Effects of Sevoflurane and Propofol on QT Interval and Heterologously Expressed Human Ether-A-Go-Go Related Gene Currents in Xenopus Oocytes Anesth. Analg., January 1, 2006; 102(1): 98 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lin, J. Guo, H. Gang, P. Wojciechowski, J. T. Wigle, and S. Zhang Intracellular K+ Is Required for the Inactivation-Induced High-Affinity Binding of Cisapride to HERG Channels Mol. Pharmacol., September 1, 2005; 68(3): 855 - 865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Calloe, P. Elmedyb, S.-P. Olesen, N. K. Jorgensen, and M. Grunnet Hypoosmotic Cell Swelling as a Novel Mechanism for Modulation of Cloned HCN2 Channels Biophys. J., September 1, 2005; 89(3): 2159 - 2169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-Y. Choi, Y.-S. Koh, and S.-H. Jo Inhibition of Human ether-a-go-go-Related Gene K+ Channel and IKr of Guinea Pig Cardiomyocytes by Antipsychotic Drug Trifluoperazine J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 888 - 895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sturm, S. Wimmers, J. R Schwarz, and C. K Bauer Extracellular potassium effects are conserved within the rat erg K+ channel family J. Physiol., April 15, 2005; 564(2): 329 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Clancy and R. S. Kass Inherited and Acquired Vulnerability to Ventricular Arrhythmias: Cardiac Na+ and K+ Channels Physiol Rev, January 1, 2005; 85(1): 33 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhang, J. Liu, and G.-N. Tseng Gating Charges in the Activation and Inactivation Processes of the hERG Channel J. Gen. Physiol., November 29, 2004; 124(6): 703 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Garcia-Ferreiro, D. Kerschensteiner, F. Major, F. Monje, W. Stuhmer, and L. A. Pardo Mechanism of Block of hEag1 K+ Channels by Imipramine and Astemizole J. Gen. Physiol., September 27, 2004; 124(4): 301 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Subbiah, C. E. Clarke, D. J. Smith, J. Zhao, T. J. Campbell, and J. I. Vandenberg Molecular basis of slow activation of the human ether-a-go-go related gene potassium channel J. Physiol., July 15, 2004; 558(2): 417 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. L. Bett and R. L. Rasmusson Inactivation and recovery in Kv1.4 K+ channels: lipophilic interactions at the intracellular mouth of the pore J. Physiol., April 1, 2004; 556(1): 109 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Antzelevitch, L. Belardinelli, L. Wu, H. Fraser, A. C. Zygmunt, A. Burashnikov, J. M. Di Diego, J. M. Fish, J. M. Cordeiro, R. J. Goodrow Jr, et al. Electrophysiologic Properties and Antiarrhythmic Actions of a Novel Antianginal Agent Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S65 - S83. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Thomas, J. Kiehn, H. A Katus, and C. A Karle Defective protein trafficking in hERG-associated hereditary long QT syndrome (LQT2): molecular mechanisms and restoration of intracellular protein processing Cardiovasc Res, November 1, 2003; 60(2): 235 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Liu, S. Konig, M. Michel, S. Arnaudeau, J. Fischer-Lougheed, C. R. Bader, and L. Bernheim Acceleration of human myoblast fusion by depolarization: graded Ca2+ signals involved Development, August 1, 2003; 130(15): 3437 - 3446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Thomas, W. Zhang, K. Wu, A.-B. Wimmer, B. Gut, G. Wendt-Nordahl, S. Kathofer, V. A.W. Kreye, H. A. Katus, W. Schoels, et al. Regulation of HERG potassium channel activation by protein kinase C independent of direct phosphorylation of the channel protein Cardiovasc Res, July 1, 2003; 59(1): 14 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ishii, M. Nagai, M. Takahashi, and M. Endoh Dissociation of E-4031 from the HERG channel caused by mutations of an amino acid results in greater block at high stimulation frequency Cardiovasc Res, March 1, 2003; 57(3): 651 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wang, K. Della Penna, H. Wang, J. Karczewski, T. M. Connolly, K. S. Koblan, P. B. Bennett, and J. J. Salata Functional and pharmacological properties of canine ERG potassium channels Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H256 - H267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Mullins, S. Z. Stepanovic, R. R. Desai, A. L. George Jr., and J. R. Balser Extracellular Sodium Interacts with the HERG Channel at an Outer Pore Site J. Gen. Physiol., September 30, 2002; 120(4): 517 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-B. Park, H. Choe, Y.-K. Lee, K.-C. Ha, K.-S. Rhee, J.-K. Ko, C.-U. Joo, S.-W. Chae, and Y.-G. Kwak Open Channel Block by KCB-328 [1-(2-Amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxyphenethyl)-N-methylamino]ethane Hydrochloride] of the Heterologously Expressed Human Ether-a-go-go-Related Gene K+ Channels J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 314 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ficker, C. A. Obejero-Paz, S. Zhao, and A. M. Brown The Binding Site for Channel Blockers That Rescue Misprocessed Human Long QT Syndrome Type 2 ether-a-gogo-related Gene (HERG) Mutations J. Biol. Chem., February 8, 2002; 277(7): 4989 - 4998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Thomas, B. Gut, G. Wendt-Nordahl, and J. Kiehn The Antidepressant Drug Fluoxetine Is an Inhibitor of Human Ether-A-Go-Go-Related Gene (HERG) Potassium Channels J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 543 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A Karle, E. Zitron, W. Zhang, S. Kathofer, W. Schoels, and J. Kiehn Rapid component IKr of the guinea-pig cardiac delayed rectifier K+ current is inhibited by {beta}1-adrenoreceptor activation, via cAMP/protein kinase A-dependent pathways Cardiovasc Res, February 1, 2002; 53(2): 355 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A Karle and J. Kiehn An ion channel 'addicted' to ether, alcohol and cocaine: the HERG potassium channel Cardiovasc Res, January 1, 2002; 53(1): 6 - 8. [Full Text] [PDF]
|
|
|
|
|
|
E. Ficker, W. Jarolimek, and A. M. Brown Molecular Determinants of Inactivation and Dofetilide Block in ether a-go-go (EAG) Channels and EAG-Related K+ Channels Mol. Pharmacol., December 1, 2001; 60(6): 1343 - 1348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.E. Lacerda, J. Kramer, K.-Z. Shen, D. Thomas, and A.M. Brown Comparison of block among cloned cardiac potassium channels by non-antiarrhythmic drugs Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K23 - K30. [Abstract] [PDF]
|
|
|
|
|
|
D. Thomas, G. Wendt-Nordahl, K. Röckl, E. Ficker, A. M. Brown, and J. Kiehn High-Affinity Blockade of Human Ether-A-Go-Go-Related Gene Human Cardiac Potassium Channels by the Novel Antiarrhythmic Drug BRL-32872 J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 753 - 761. [Abstract] [Full Text]
|
|
|
|
|
|
J. Bérubé, D. Caouette, and P. Daleau Hydrogen Peroxide Modifies the Kinetics of HERG Channel Expressed in a Mammalian Cell Line J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 96 - 102. [Abstract] [Full Text]
|
|
|
|
|
|
M. E. O'Leary Inhibition of Human Ether-A-Go-Go Potassium Channels by Cocaine Mol. Pharmacol., February 1, 2001; 59(2): 269 - 277. [Abstract] [Full Text]
|
|
|
|
|
|
C. A Karle, V. A.W Kreye, D. Thomas, K. Rockl, S. Kathofer, W. Zhang, and J. Kiehn Antiarrhythmic drug carvedilol inhibits HERG potassium channels Cardiovasc Res, February 1, 2001; 49(2): 361 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Numaguchi, F. M. Mullins, J. P. Johnson Jr., D. C. Johns, S. S. Po, I. C.-H. Yang, G. F. Tomaselli, and J. R. Balser Probing the Interaction Between Inactivation Gating and Dd-Sotalol Block of HERG Circ. Res., November 24, 2000; 87(11): 1012 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Emmi, H. J. Wenzel, P. A. Schwartzkroin, M. Taglialatela, P. Castaldo, L. Bianchi, J. Nerbonne, G. A. Robertson, and D. Janigro Do Glia Have Heart? Expression and Functional Role for Ether-A-Go-Go Currents in Hippocampal Astrocytes J. Neurosci., May 15, 2000; 20(10): 3915 - 3925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Lees-Miller, Y. Duan, G. Q. Teng, and H. J. Duff Molecular Determinant of High-Affinity Dofetilide Binding to HERG1 Expressed in Xenopus Oocytes: Involvement of S6 Sites Mol. Pharmacol., February 1, 2000; 57(2): 367 - 374. [Abstract] [Full Text]
|
|
|
|
|
|
M. Jiang, W. Dun, J.-S. Fan, and G.-N. Tseng Use-Dependent `Agonist' Effect of Azimilide on the HERG Channel J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1324 - 1336. [Abstract] [Full Text]
|
|
|
|
|
|
D. Thomas, W. Zhang, C. A. Karle, S. Kathofer, W. Schols, W. Kubler, and J. Kiehn Deletion of Protein Kinase A Phosphorylation Sites in the HERG Potassium Channel Inhibits Activation Shift by Protein Kinase A J. Biol. Chem., September 24, 1999; 274(39): 27457 - 27462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kiehn, A. E. Lacerda, and A. M. Brown Pathways of HERG inactivation Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H199 - H210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Zhang, Z. Zhou, Q. Gong, J. C. Makielski, and C. T. January Mechanism of Block and Identification of the Verapamil Binding Domain to HERG Potassium Channels Circ. Res., May 14, 1999; 84(9): 989 - 998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kiehn, C. Karle, D. Thomas, X. Yao, J. Brachmann, and W. Kubler HERG Potassium Channel Activation Is Shifted by Phorbol Esters via Protein Kinase A-dependent Pathways J. Biol. Chem., September 25, 1998; 273(39): 25285 - 25291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhou, Q. Gong, M. L. Epstein, and C. T. January HERG Channel Dysfunction in Human Long QT Syndrome. INTRACELLULAR TRANSPORT AND FUNCTIONAL DEFECTS J. Biol. Chem., August 14, 1998; 273(33): 21061 - 21066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Rampe, M. K. Murawsky, J. Grau, and E. W. Lewis The Antipsychotic Agent Sertindole is a High Affinity Antagonist of the Human Cardiac Potassium Channel HERG J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 788 - 793. [Abstract] [Full Text]
|
|
|
|
|
|
R. L. Rasmusson, M. J. Morales, S. Wang, S. Liu, D. L. Campbell, M. V. Brahmajothi, and H. C. Strauss Inactivation of Voltage-Gated Cardiac K+ Channels Circ. Res., April 20, 1998; 82(7): 739 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nattel Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs Cardiovasc Res, March 1, 1998; 37(3): 567 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ficker, W. Jarolimek, J. Kiehn, A. Baumann, and A. M. Brown Molecular Determinants of Dofetilide Block of HERG K+ Channels Circ. Res., February 23, 1998; 82(3): 386 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Lees-Miller, C. Kondo, L. Wang, and H. J. Duff Electrophysiological Characterization of an Alternatively Processed ERG K+ Channel in Mouse and Human Hearts Circ. Res., November 19, 1997; 81(5): 719 - 726. [Abstract] [Full Text]
|
|
|
|
|
|
E. A. Accili, J. Kiehn, Q. Yang, Z. Wang, A. M. Brown, and B. A. Wible Separable Kvbeta Subunit Domains Alter Expression and Gating of Potassium Channels J. Biol. Chem., October 10, 1997; 272(41): 25824 - 25831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kathofer, W. Zhang, C. Karle, D. Thomas, W. Schoels, and J. Kiehn Functional Coupling of Human beta 3-Adrenoreceptors to the KvLQT1/MinK Potassium Channel J. Biol. Chem., August 25, 2000; 275(35): 26743 - 26747. [Abstract] [Full Text] [PDF]
|
|